纵隔与主动脉旁胸部淋巴结示踪剂摄取为PSMA配体PET/CT图像解读的潜在陷阱
该回顾性研究纳入两组接受双时相68Ga-PSMA-11 PET/CT的前列腺癌患者,比较无淋巴结转移组纵隔/主动脉旁淋巴结与转移组淋巴结的SUV,并对22枚无前列腺癌患者的淋巴结行PSMA免疫组化分析。无转移组部分患者可见PSMA阳性纵隔淋巴结,但其摄取显著低于转移淋巴结且通常随时间下降。
要点
- 无淋巴结转移组中7/38例(18.4%)在注射后1小时可见至少一枚PSMA阳性纵隔淋巴结。
- 纵隔/主动脉旁良性淋巴结SUVmax在注射后1小时为2.3±0.7,3小时为2.0±0.7。
- 淋巴结转移灶SUVmax在注射后1小时为12.5±13.2,3小时为15.8±17.0。
核心结论
- 相当比例患者可见PSMA阳性的纵隔/主动脉旁良性淋巴结。
- 组织病理学层面的PSMA阳性与淋巴结活化状态相关。
- 与前列腺癌淋巴结转移灶不同,良性淋巴结摄取显著更低且通常随时间下降。
研究设计与样本
- 回顾性评估纳入两组接受双时相68Ga-PSMA-11 PET/CT(注射后1小时与3小时)的患者。
- A组为无淋巴结转移的前列腺癌患者38例,B组为有淋巴结转移的前列腺癌患者43例。
- 比较A组100枚纵隔/主动脉旁淋巴结与B组91枚转移淋巴结的SUV。
- 另对无前列腺癌患者的22枚随机选取纵隔/主动脉旁淋巴结行PSMA免疫组化分析。
主要发现
- A组7/38例(18.4%)在注射后1小时至少有一枚PSMA阳性纵隔淋巴结,3/38例(7.9%)在注射后3小时有阳性淋巴结。
- A组纵隔/主动脉旁淋巴结SUVmax在注射后1小时为2.3±0.7,3小时为2.0±0.7。
- 结合两个显像时间点,9例患者共检出11枚PSMA阳性纵隔/主动脉旁淋巴结。
- B组淋巴结转移灶SUVmax在注射后1小时为12.5±13.2,3小时为15.8±17.0。
- 76.9%的淋巴结转移灶SUVmax在1小时至3小时之间明显升高(>10%),72.7%的纵隔/主动脉旁淋巴结SUVmax显著下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Since the introduction of 68Ga-PSMA-11 PET/CT for imaging prostate cancer (PC) we have frequently observed mediastinal lymph nodes (LN) showing tracer uptake despite being classified as benign. The aim of this evaluation was to further analyze such LN. METHODS: Two patient groups with biphasic 68Ga-PSMA-11 PET/CT at 1 h and 3 h p.i. were included in this retrospective evaluation. Group A (n = 38) included patients without LN metastases, and group B (n = 43) patients with LN metastases of PC. SUV of mediastinal/paraaortal LN of group A (n = 100) were compared to SUV of LN metastases of group B (n = 91). Additionally, 22 randomly selected mediastinal and paraaortal LN of patients without PC were immunohistochemically (IHC) analyzed for PSMA expression. RESULTS: In group A, 7/38 patients (18.4%) presented with at least one PSMA-positive mediastinal LN at 1 h p.i. and 3/38 (7.9%) positive LN at 3 h p.i. with a SUVmax of 2.3 ± 0.7 at 1 h p.i. (2.0 ± 0.7 at 3 h p.i.). A total of 11 PSMA-positive mediastinal/paraaortal LN were detected in nine patients considering both imaging timing points. SUVmax of LN-metastases was 12.5 ± 13.2 at 1 h p.i. (15.8 ± 17.0 at 3 h p.i.). SUVmax increased clearly (> 10%) between 1 h and 3 h p.i. in 76.9% of the LN metastases, and decreased significantly in 72.7% of the mediastinal/paraaortal LN. By IHC, PSMA-expression was observed in intranodal vascular endothelia of all investigated LN groups and to differing degrees within germinal centers of 15/22 of them (68.1%). Expression was stronger in mediastinal nodes (p = 0.038) and when follicular hyperplasia was present (p = 0.050). CONCLUSION: PSMA-positive mediastinal/paraaortal benign LN were visible in a notable proportion of patients. PSMA-positivity on the histopathological level was associated with the activation state of the LN. However, in contrast to LN metastases of PC, they presented with significantly lower uptake, which, in addition, usually decreased over time.
引用
- Afshar-Oromieh A, Sattler LP, Steiger K, et al. Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT. Eur J Nucl Med Mol Imaging. 2018. PMID: 29497802. doi:10.1007/s00259-018-3965-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。